Devices and Wearables Library
Every article, presentation, spotlight, and news item we've tagged to Devices and Wearables.
Showing 49–55 of 55
Science Corp and Neurosoft unite to speed brain-computer care
A partnership between Science Corporation and Neurosoft Bioelectronics reduces brain-computer interface development costs from $75–100 million to under $5 million, accelerating clinical adoption of therapies for neurological conditions including epilepsy and tinnitus. For longevity practitioners, this infrastructure advancement enables faster restoration of neurological function and cognitive independence—essential dimensions of healthspan that outlive lifespan alone.
Nanotech startup lands funding for continuous biosensing platform
Xsensio has secured $7 million in Series A funding to advance a wearable biosensing platform that continuously monitors multiple biomarkers in interstitial fluid, initially targeting early detection of organ dysfunction in acute care settings. Real-time access to biochemical data at the point of care represents a shift from periodic laboratory measurement to continuous physiological surveillance, with potential implications for earlier clinical intervention.
Blood Biomarkers Close Alzheimer's Diagnostic Gap in Latin America
C2N Diagnostics and SouthGenetics are expanding blood-based biomarker testing for Alzheimer's detection across Latin America and the Caribbean, addressing a critical gap between diagnostic innovation and accessibility in underserved regions. This partnership prioritizes implementation over technology alone, recognizing that earlier identification of Alzheimer's pathology becomes actionable only when systems can deploy it at scale.
Designing therapies patients can live with
Light-activated photodynamic therapy for cutaneous T-cell lymphoma demonstrates a treatment design principle critical to chronic disease management: therapies must be engineered for decades of safe, repeatable use rather than optimized solely for efficacy. For conditions that persist across a lifespan, cumulative toxicity and patient burden become as clinically significant as the primary disease.
Alzheimer's Therapies Shift Detection From Clinic to Home
Effective disease-modifying therapies for Alzheimer's disease are forcing a diagnostic infrastructure shift from academic research to scalable clinical detection. Early identification now determines treatment efficacy, requiring systems that can identify pathology years before cognitive symptoms emerge.
AliveCor shrinks the ECG and speeds up diagnosis
AliveCor's Kardia 12L is a handheld, AI-assisted device that captures 12-lead ECG-quality cardiac data with simplified hardware and reduced setup time. The CE-marked system detects 35 cardiac conditions and reduces testing time by approximately one-third, extending hospital-grade diagnostic capacity into primary care, rural, and home settings.
YOU(th) lands funding for smartphone-based preventive health screening
YOU(th) has secured $4.5 million to advance a smartphone-based screening platform that analyzes facial video, voice, eye images, and movement patterns to assess over 50 digital biomarkers across multiple organ systems in under two minutes. The approach aims to reduce friction in preventive health screening by leveraging ubiquitous smartphone sensors to detect physiological and metabolic signals outside traditional clinical settings.